Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles

被引：13
|
作者：
Ricciarelli, E [1 ]
Sanchez, M [1 ]
Martinez, M [1 ]
Andres, L [1 ]
Cuadros, J [1 ]
Hernandez, ER [1 ]
机构：
[1] Clin Med Reprod & Ginecol FIVMadrid, Madrid 28006, Spain
来源：
FERTILITY AND STERILITY | 2003年 / 79卷 / 06期
关键词：
D O I：
10.1016/S0015-0282(03)00388-1
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1461 / 1463
页数：3
相关论文
共 50 条
  • [1] Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles
    Lee, Jung Ryeol
    Choi, Young Sik
    Jee, Byung Chul
    Ku, Seung-Yup
    Suh, Chang Suk
    Kim, Ki Chul
    Lee, Won Don
    Kim, Seok Hyun
    FERTILITY AND STERILITY, 2007, 88 (05) : 1344 - 1349
  • [2] Progesterone administration route in gonadotropin-releasing hormone antagonist cycles
    Bahceci, Mustafa
    Ulug, Ulun
    FERTILITY AND STERILITY, 2010, 94 (03) : E47 - E47
  • [3] Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial
    Giles, Juan
    Alama, Pilar
    Gamiz, Pilar
    Vidal, Carmen
    Badia, Paloma
    Pellicer, Antonio
    Bosch, Ernesto
    FERTILITY AND STERILITY, 2021, 116 (02) : 404 - 412
  • [4] The impact of luteinizing hormone supplementation in gonadotropin-releasing hormone antagonist cycles: a retrospective cohort study
    He, Wen
    Lin, Hui
    Lv, Jie
    Wen, Yanfei
    Cai, Liuhong
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (06) : 513 - 517
  • [5] Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study
    Bodri, Daniel
    Guillen, Juan Jose
    Galindo, Anna
    Mataro, Daniel
    Pujol, Aida
    Coll, Oriol
    FERTILITY AND STERILITY, 2009, 91 (02) : 365 - 371
  • [6] Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
    Youssef, Mohamed A. F. M.
    Van der Veen, Fulco
    Al-Inany, Hesham G.
    Griesinger, Georg
    Mochtar, Monique H.
    Aboulfoutouh, Ismail
    Khattab, Sherif M.
    van Wely, Madelon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (01):
  • [7] Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
    Youssef, Mohamed A. F. M.
    Van der Veen, Fulco
    Al-Inany, Hesham G.
    Griesinger, Georg
    Mochtar, Monique H.
    van Wely, Madelon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (11):
  • [8] Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis
    Bosch, Ernesto
    Labarta, Elena
    Crespo, Juana
    Simon, Carlos
    Remohi, Jose
    Pellicer, Antonio
    FERTILITY AND STERILITY, 2011, 95 (03) : 1031 - 1036
  • [9] Progesterone administration route in gonadotropin-releasing hormone antagonist cycles Reply
    Kahraman, Semra
    Karagozoglu, S. Hale
    Karlikaya, Guvenc
    FERTILITY AND STERILITY, 2010, 94 (03) : E48 - E48
  • [10] Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles
    Shapiro, Bruce S.
    Daneshmand, Said T.
    Garner, Forest C.
    Aguirre, Martha
    Ross, Richard
    FERTILITY AND STERILITY, 2007, 88 (01) : 237 - 239
12345